New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For REGN From The Last 14 Days
Check below for free stories on REGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
08:04 EDTREGNRegeneron price target raised to $436 from $389 at Leerink
Leerink raised its price target for Regeneron shares to $436 after its survey of 100 physicians indicated potential blockbuster status for the company's PCSK9-inhibitor Alirocumab. The firm reiterates an Outperform rating on the stock.
07:21 EDTREGNRegeneron data positive, says RBC Capital
Subscribe for More Information
07:14 EDTREGNRegeneron price target raised to $400 from $340 at Credit Suisse
Subscribe for More Information
August 31, 2014
14:22 EDTREGNSanofi, Regeneron announce results from four Phase 3 ODYSSEY trials
Subscribe for More Information
13:59 EDTREGNRW Baird to hold a conference
Subscribe for More Information
13:41 EDTREGNCitigroup to hold a conference
Subscribe for More Information
12:50 EDTREGNEuropean Society of Cardiology to hold a conference
Subscribe for More Information
August 29, 2014
12:23 EDTREGNNovartis drug data to be presented this weekend
Subscribe for More Information
August 25, 2014
11:48 EDTREGNSanofi and Regeneron co-host a conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use